- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22:46 | Ipsen's $450M Deal Brings Drug That Could Make a Standard Blood Cancer Therapy Better | ||
| 16:46 | Federal Loan Policy Is Pricing Women Out of Healthcare's Most Critical Roles | ||
| 15:46 | Radiologists Need AI That Works Where They Work, Not Standalone Software | ||
| 15:35 | Don't Celebrate the Wrong Win: What CMS-0053-F Actually Changes | ||
| So | FDA Approves Viridian's Thyroid Eye Disease Drug, Competitor to a Blockbuster Amgen Med | ||
| So | CMS Recalculates Star Ratings - Again | ||
| So | A Bridge to Nowhere? Medicare's GLP-1 Coverage Expansion Requires A More Holistic Approach To Weight Management | ||
| So | Healthcare's Most Avoided Question: "How Much Exactly Do You Need, and What Will America Get in Return?" | ||
| So | 3 Traps Health Systems Fall Into When Trying to Improve Their Culture | ||
| So | The Terminology Gap Undermining Cervical Cancer Screening Guidelines | ||
| Fr | New Bill Led by Democrats Aims to Cap Medicare Out-of-Pocket Costs | ||
| Fr | Documentation Tools Aren't Just for Doctors: Inside Reid Health's Deployment of Abridge's Nurse Tech | ||
| Fr | Why Generative AI Isn't Enough: The Case for Causal Reasoning in Medicine | ||
| Fr | The Hidden Cost of "Good Enough" in Healthcare Experiences | ||
| Fr | Have Healthcare Data Lakes Become "Data Swamps"? | ||
| Fr | Why 'Still Open' Is the Wrong Way to Measure the Hospital Crisis | ||
| Fr | A Metabolic Disease Posing Severe Pancreatic Risks Gets Its First FDA-Approved Therapy | ||
| Fr | Upside Seeks to Solve the Housing Crisis Armed with $20M Raise | ||
| Fr | UnitedHealthcare Threw Open Its HQ to Journalists and Influencers. Why? | ||
| Do | Why Most Healthcare AI Fails After the Pilot Phase | ||
| Do | Real-Time Trials Are Here - Now We Need Real-Time Trust | ||
| Do | Where Patient Education Breaks Down in Breast Cancer Care | ||
| Do | How Are Payers and Providers Thinking of AI and Cybersecurity? | ||
| Do | New FDA Nod Keeps Gilead Drug Competitive With AstraZeneca & Daiichi in Breast Cancer | ||
| Do | New Partnership Aims to Lower Out-of-Pocket Costs, Even Eliminate Them In Some Cases |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.